Hold-rated reports

932 tickers rated Hold
Ranks this page's recent reports by score.
ReNew Energy Global Plc
RNW·Utilities
B ★★★Hold
Current$6.81
Target$7.02
Return+3.1%
Aug 26, 2026

ReNew is poised for a definitive take-private buyout at $7.02 per share, offering a low-risk merger arbitrage play, though investors must monitor regulatory and shareholder approval hurdles before the March 2027 deadline.

Score
75
Pony AI Inc.
PONY·Technology
B ★★★Hold
Current$8.23
Target$10.26
Return+24.7%
Aug 26, 2026

Pony AI is a fiercely innovative, heavily capitalized global pioneer in autonomous mobility scaling a highly disruptive, asset-light international Robotaxi network, though its currently inflated sales multiples demand absolute execution perfection in the face of immense geopolitical and regulatory headwinds.

Score
76
Celldex Therapeutics, Inc.
CLDX·Healthcare
B ★★★Hold
Current$40.38
Target$72.00
Return+78.3%
Aug 26, 2026

Celldex is an exceptionally well-capitalized immunology pioneer positioned to dominate the multi-billion dollar chronic urticaria market with a highly de-risked biological asset, though investors must tolerate extreme binary volatility pending the ultimate validation of its Phase 3 clinical data.

Score
77
ePlus inc.
PLUS·Technology
B ★★★Hold
Current$86.85
Target$111.00
Return+27.8%
Aug 25, 2026

ePlus is a fundamentally pristine, highly cash-generative IT infrastructure tollbooth successfully pivoting toward high-margin cloud services, but near-term upside remains heavily capped by intense enterprise hardware margin compression and a cautious wave of executive insider selling.

Score
75
Ouster, Inc.
OUST·Technology
B ★★★Hold
Current$38.42
Target$52.64
Return+37.0%
Aug 25, 2026

Ouster is shifting from commoditized lidar hardware toward a high-margin, sticky Physical AI software platform, but continued dilution and margin pressure from Chinese rivals warrant caution.

Score
78
Vericel Corporation
VCEL·Healthcare
B ★★★Hold
Current$44.26
Target$57.20
Return+29.2%
Aug 25, 2026

Vericel operates a monopolistic, high-margin autologous cell therapy engine transitioning into a cash-generating powerhouse, though its premium valuation requires flawless execution in the MACI Arthro rollout to prevent multiple compression.

Score
76
Talos Energy Inc.
TALO·Energy
B ★★★Hold
Current$17.47
Target$21.00
Return+20.2%
Aug 25, 2026

Talos Energy is a cash-generating, efficient deepwater operator positioned to extract value from recent acquisitions and Mexican assets, but its heavy concentration in the Gulf of Mexico caps its multiple in a volatile commodity market.

Score
83
Denison Mines Corp.
DNN·Energy
B ★★★Hold
Current$3.50
Target$5.38
Return+53.7%
Aug 25, 2026

Denison Mines offers non-dilutive exposure to the nuclear renaissance through its low-cost Phoenix ISR uranium project and fortress balance sheet, though pioneering freezing techniques in the Athabasca Basin carries severe binary execution risk.

Score
84
Guardian Pharmacy Services, Inc.
GRDN·Healthcare
B ★★★Hold
Current$37.93
Target$43.52
Return+14.7%
Aug 25, 2026

Guardian is a highly profitable, cash-generative tollbooth for the aging ALF population, yet investors should wait for the upcoming Class B share conversion and persistent IRA pricing headwinds to provide a more attractive entry multiple.

Score
76
Kennametal Inc.
KMT·Industrials
B ★★★Hold
Current$29.96
Target$37.20
Return+24.2%
Aug 25, 2026

Kennametal is a defensible, technologically entrenched industrial tooling leader at distressed valuation lows, but investors must endure severe near-term margin compression and negative cash flow as it unwinds an ill-timed raw material inventory build.

Score
75
PagSeguro Digital Ltd.
PAGS·Technology
B ★★★Hold
Current$8.62
Target$11.76
Return+36.4%
Aug 25, 2026

PagSeguro is a profoundly undervalued, cash-printing digital banking powerhouse dominating Brazilian micro-merchants, though investors must stomach extreme volatility tied to Latin American interest rates and relentless fintech competition.

Score
83
A10 Networks, Inc.
ATEN·Technology
B ★★★Hold
Current$26.12
Target$38.40
Return+47.0%
Aug 25, 2026

A10 Networks is a highly profitable, cash-gushing tollbooth for the global AI infrastructure buildout, executing flawless margin expansion and capital returns, though investors must remain hyper-vigilant regarding its extreme revenue concentration with Microsoft and historically stretched valuation multiples.

Score
79